TITLE

Compound from breast implants linked to cancer

AUTHOR(S)
Park, Penny; Brown, Phyllida
PUB. DATE
May 1991
SOURCE
New Scientist;5/11/81, Vol. 130 Issue 1768, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the withdrawal from the market of two types of breast implants due to fears that they could cause cancer. Tests by the US Food and Drug Administration; How the implants, Meme and Replicon are different from other types of implants; Release of a compound called 2,4 toluene diamine (TDA); How many women in North America, Europe and Australia have the implants; The FDA's `worst-case' estimate of risk; More.
ACCESSION #
9106031583

 

Related Articles

  • FDA APPROVES NEW BREAST IMPLANT OPTIONS.  // American Spa;Sep2013, Vol. 17 Issue 9, p70 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) on Mentor Worldwide MemoryShape Breast Implants as a new option for breast enhancement and reconstructive surgery.

  • The 'breast' choice.  // Dermatology Times;Winter2010 In The Know Supplement, p12 

    The article presents information on saline and silicone implants which most women have in comment when considering a breast augmentation. It mentions their history background which silicone breast implants were said to been ban by the Food and Drug Administration (FDA) in the 1990s due to its...

  • Solid Strategies in Revisional Breast Surgery. Oliver Jr., Robert // Plastic Surgery Products;Apr2008, Vol. 18 Issue 5, p28 

    The article presents a discussion about reoperation of women who underwent breast augmentation. According to data collected by Allergan Inc. and Mentor Corp. submitted to the U.S. Food and Drug Administration (FDA), reoperation rates of women within 5 years of surgery are high. One factor that...

  • silicone valleys. Brown, Sarah // Vogue;Apr2007, Vol. 197 Issue 4, p370 

    The article discusses the increase in the number of silicone breast implants in the U.S. In relation to this, the Food and Drug Administration (FDA) has lifted the fourteen-year-old ban on silicone implants in 2006. Until November 2006, saline implants, which are filled with salt water, were the...

  • FDA takes step toward silicone implant approval. C. S. T. // Cosmetic Surgery Times;Sep2005, Vol. 8 Issue 8, p1 

    The article reports on the U.S. Food and Drug Administration's (FDA) decision to approve Mentor Corp.'s silicone breast implants. The committee said that Mentor Corp. must meet in order to receive FDA approval to market and sell silicone breast implants in the United States. These include...

  • Interference of breast implants with echocardiographic image acquisition and interpretation. Movahed, Mohammad-Reza // Cardiovascular Ultrasound;2007, Vol. 5, p9 

    Echocardiography is one of the most important diagnostic testing in cardiology. The presence of a breast implant overlying heart can cause significant impairment of the echocardiographic acoustic window. Breast implants are increasing in popularity in the USA and the Federal Drug and Food...

  • Health Risk or a Woman's Choice? Querna, Elizabeth // U.S. News & World Report;4/25/2005, Vol. 138 Issue 15, p57 

    Discusses emotionally charged hearings at a Food and Drug Administration advisory panel meeting on whether silicone breast implants should be restricted as a health hazard or offered as a woman's personal choice. FDA panel recommendation to approve Mentor's silicone implant while rejecting...

  • ARE BREAST IMPLANTS ACTUALLY OK? Angell, Marcia // New Republic;9/11/95, Vol. 213 Issue 11, p17 

    Asserts that the only way to learn the health effects of breast implants is through careful research and unbiased interpretation of results. Response of women to the decision of U.S. Food and Drug Administration Commissioner David Kessler to ban silicone gel-filled breast implants; Number of...

  • FDA issues advisory about silicone implants. Moore, Miles // Rubber & Plastics News;2/7/2011, Vol. 40 Issue 14, p11 

    The article discusses a study conducted by the U.S. the Food and Drug Administration (FDA) according to which women with silicone-gel or saline breast implants may face the risk of anaplastic large cell lymphoma (ALCL). According to FDA, it reviewed 34 cases of ALCL in breast implant recipients....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics